¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress : 2021-04-24

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 
½ÉÀå´ë»çÁõÈıºÇÐȸ 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress : 2021-04-24
±³À°ÀÏÀÚ : 2021-04-24
±³À°Àå¼Ò : ¿Â¶óÀÎ & ¿ÀÇÁ¶óÀÎ µ¿½Ã °³ÃÖ_ ¿ÀÇÁ¶óÀÎ: ÄÜ·¡µå ¼­¿ï È£ÅÚ 5Ãþ ÆÄÅ©º¼·ë¿Ü 2°³·ë  
±³À°ÁÖÁ¦ : (¿Â¶óÀÎ&¿ÀÇÁ¶óÀÎ º´Çà) 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ  
´ã´çÀÚ : ÀÌÈ¿Áø
¿¬¶ôó : 032-460-3663  
À̸ÞÀÏ : secret9595@naver.com      
±³À°Á¾·ù : ³»°ú      
Âü¼®¿¹»óÀοø : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡  
Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 15 ½Ã°£ 22ºÐ  
¼¼ºÎ¼ö°­·á : 100,000¿ø      
ºñ°í »çÀüµî·Ï¸¸ ÁøÇà : M.D. / Ph.D. : 100,000 KRW ±âŸ : 30,000 KRW * ·Î±×ÀÎÀº Çà»ç ´çÀϸ¸ Á¢¼Ó °¡´ÉÇÕ´Ï´Ù.      

±¸ºÐ ¿ùÀÏ °­ÀǽǠ½Ã°£ ±³À°Á¦¸ñ  °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 1 08:10~08:40 Importance of Dyslipidemia Management in Patients with Endocrine Disorders : Focus on DM Patients  Sung Hee Choi(Seoul National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 2 08:10~08:40 Interim Analysis of APOLLO Study: 1 Year Follow-up Results  Seung-Woon Rha(Korea University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë 3 08:10~08:40 Optimal Anti-Hypertensives in CardioMetabolic Diseases with Hypertension  Sang Min Park(Eulji University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©½ºÆ©µð¿À 08:10~08:40 Patient-Centered Approach to LDL-C Management Post-ACS  Kyounghoon Lee(Gachon University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:00~09:20 Role of Vimentin in Atherosclerosis  Young Mi Park(Ewha Womans University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:20~09:40 Deciphering the Role of Macrophages in Hyperlipidemic Cardiovascular Diseases  Jae-Hoon Choi(Hanyang University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 09:40~10:00 ANGPTL4 in Cardiovascular Diseases  Yong Sook Kim(Chonnam National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 10:00~10:20 Rescue of Cardiac Remodeling in Diabetic Hearts by Activating Calcium/Calmodulin-Dependent Protein Kinase Kinase 2  Jin Han(Inje University Korea) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 10:20~10:35 Discussion  All Panelists() 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:00~09:20 Epicardial Adipose Tissue and Heart  Seong-Mi Park(Korea University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:20~09:40 Diabetes and Heart Function  Yong Li(Fudan University China) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 09:40~10:00 Characteristics of Koreans in Metabolic Syndrome  Mi-Seung Shin(Gachon University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 10:00~10:20 Paradigm Shift in Anti-Diabetic Strategy: Focus on Cardiovascular Benefits  Neng Dai(Fudan University China) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë B 10:20~10:35 Discussion  All Panelists() 
È޽Ġ04-24  10:35~10:55 Break  () 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 10:55~11:15 Medical Therapy  Jon Suh(SoonChunHyang University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 11:15~11:35 PCI  Cheol Ung Choi(Korea University Korea) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 11:35~11:55 Discussion  All Panelists() 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 10:55~11:10 Integrated Management of Hypertension Complicated with Hyperlipidemia from China  Tang Yida(Peking University Third Hospital China) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 11:10~11:25 New Strategies to Lipid Modification to Reduce Residual ASCVD Risk in 2021  Dao-Quan Peng(Central South University China) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 11:25~11:40 Triglyceride and Residual Risk of MACE  Won Kim(Kyunghee University Korea) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë B 11:40~11:55 Discussion  All Panelists() 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 12:05~12:30 Are Statins All the Same in Outcome and Safety for Asian?  Ki-Hyun Jeon(Seoul National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 12:05~12:30 Appropriate Statin Therapy for Primary Prevention  Jong-Young Lee(Sungkyunkwan University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A,B 13:10~13:50 Lipoprotein(a) and Cardiovascular Diseases: Past, Present, and Future  Kwang Kon Koh(Gachon University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:00~14:20 Metformin as Medications for Cardiometabolic Risk?  Sangmo Hong(Hanyang University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:20~14:40 New PPARa Agonist  Ichiro Sakuma(Health Science University of Hokkaido Japan) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 14:40~15:00 Fatty Liver and CVD  Dong Hee Kim(University of California San Francisco USA) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 15:00~15:15 Discussion  All Panelists() 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:00~14:12 Changes of Metabolic Syndrome Components According to the COVID-19 Pandemic in Stable Diabetes Mellitus Patients  Minji Sohn(Seoul National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:12~14:24 Connecting The Link Among Dental Problems, Atherosclerosis, Endocarditis, and Coronary Heart Disease  Danan Budi Primadi(Universitas Islam Indonesia) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:24~14:36 Correlation between Brain Natriuretic Peptide (BNP) Level with Cardio Metabolic Factor Among Patients Acute Heart Failure with Diabetes Mellitus  I Nyoman Indrawan Mataram(Klungkung District Hospital Indonesia) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:36~14:48 Long-Term Clinical Outcomes of Diabetic Patients with Negative Treadmill Stress Echocardiography: Worse Than Those of Non-diabetic Patients?  Soyoung Yang(Kyung Hee University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 14:48~15:00 Association of Vitamin D Deficiency with Glycemic Control and Cardio-Metabolic Risk in Type 2 Diabetes Population  Sushant Pokhrel(Manmohan Memorial Institute of Health Sciences Nepal) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 15:00~15:12 Echocardiography Segmentation Using Hierarchical Deep Learning Model for Early Screening Cardiac-Related Complications  Cam Hao Hua(Kyung Hee University Korea) 
È޽Ġ04-24  15:15~15:30 Break  () 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 15:30~16:00 Search for Novel HDL Biomarkers  Arnold von Eckardstein(University of Zurich Switzerland) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 15:30~16:00 Association of COVID-19 with Cardiovascular and Metabolic Disorders  Soo Lim(Seoul National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:00~16:20 The Role of Aspirin in CVD Prevention  Sunki Lee(Hallym University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:20~16:40 Deescalation of Antiplatelet Therapy in Patients with ACS  KyungWoo Park(Seoul National University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 16:40~17:00 NOAC in Patients with CAD  Yun Seok Choi(Catholic University Korea) 
Åä·Ð 04-24 ÆÄÅ©º¼·ë A 17:00~17:15 Discussion  All Panelists() 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:00~16:10 Solid Lipid Nanoparticle of Hesperidine Exerts Streptozotocin-Induced Cardiomyopathy via Inflammatory Pathway  Vikas Kumar(Sam Higginbottom University of Agriculture India) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:10~16:20 Associations of Physical Activity and Lower Respiratory Tract Infection Outcomes in Patients with Cardiovascular Disease  Mi-Hyang Jung(Hallym University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:20~16:30 Antiplatelet Therapy with Clopidogrel Considering with CYP2C19 Genetic Polymorphisms in Patients with Coronary Heart Disease after Coronary Artery Stenting  Jamol Uzokov(Republican specialized scientific practical medical center Uzbekistan) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:30~16:40 Effects of Silver Nanoparticles on Renal Function in Fat-Fed and Streptozotocin-Treated Rats  Pardeep Kumar(F H medical college India) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:40~16:50 Prevention of Gestational Diabetes before and during Pregnancy, Survey in Pune, India: Role of Daily Diet Leafy Green Vegetables, Fruit, and Milk.  Sumit Rajput(Chaudhary Charan Singh University India) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 16:50~17:00 Amelioration in Glycosylated Hemoglobin (HbA1c) and Homeostasis Model Assessment (HOMA) of Pancreatic ¥â-cell from Alkaloids Rich Withania Somnifera through DPP-IV Inhibition in Type-2 Diabetic Rats: in-vitro, in-vivo, in-silico  Anand-Krishna Singh(Shri Vaishnav Vidhyapeeth Vishvawidyalaya India) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë A 17:20~17:50 Controling Dyslipidemia and CV Risk with Atorvastatin and Ezetimibe  Kyounghoon Lee(Gachon University Korea) 
±³À°½Ã°£ 04-24 ÆÄÅ©º¼·ë B 17:20~17:50 Focused on Right Target Patients, Candesartan/Rosuvastatin  Jong-Chan Youn(Catholic University Korea) 
ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 4th APCMS (Asia-Pacific CardioMetabolic Syndrome) Congress : 2021-04-24""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û ´ëÇѳ»½Ã°æº¹°­°æ¿Ü°úÇÐȸ (¿Â¶óÀÎ) The KSELS 25th Anniversary & 48th Annual Congress & 11th International Symposium (KSELS 2021) : 2021-04-24
´ÙÀ½±Û (¿Â¶óÀÎ)Á¦95Â÷ ´ëÇÑÀ̺ñÀÎÈÄ°úÇÐȸ Çмú´ëȸ/2021³â Ãá°è ´ëÇÑÀ̺ñÀÎÈÄ°úÀÇ»çȸ Çмú´ëȸ in conjunction with ICORL 2021(II) : 2021-04-24
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20925 ÀüºÏ Á¦ 53Â÷ ´ëÇѳëÀκ´ÇÐȸ È£³²Áöȸ ÇмúÁý´äȸ : 2024-07-27 0 49 2024-05-28
20924 ¼­¿ï 2024 Á¦27ȸ ´ëÇѾȸ鼺ÇüÀç°ÇÇÐȸ Ãá°è Çмú´ëȸ : 2024-07-21 0 44 2024-05-28
20923 °æ±â 2024³â ÀÏ»ê¹éº´¿ø Á¤Çü¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-07-21 0 42 2024-05-28
20922 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(2ÀÏÂ÷) : 2024-07-20 0 52 2024-05-28
20921 ¼­¿ï Á¦33Â÷ ´ç´¢º´ ¿¬±¸ ÇÏ°è¿öÅ©¼¥ : 2024-07-20 0 38 2024-05-28
20920 ¼­¿ï ´ëÇÑÁ¾¾ç³»°úÇÐȸ Recent updates in GU Cancers 2024 : 2024-07-19 0 76 2024-05-28
20919 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 2Â÷(1ÀÏÂ÷) : 2024-07-19 0 29 2024-05-28
20918 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-07-14 0 42 2024-05-28
20917 °æºÏ 2024³â ´ëÇÑ°ñ´Ù°øÁõÇÐȸ ¿µ³² ¿¬¼ö°­Á : 2024-07-14 0 38 2024-05-28
20916 °æ±â ÀÎÁ¦´ëÇб³ ÀÏ»ê¹éº´¿ø ¼ÒÈ­±â³»°ú °³¿øÀÇ ¿¬¼ö°­Á : 2024-07-13 0 46 2024-05-28
20915 °æ±â 2024³â ÀÇÁ¤ºÎÀ»Áö´ëÇб³º´¿ø Á¦1ȸ ½Å°æ°ú °³¿øÀÇ ¿¬¼ö±³À° : 2024-07-13 0 44 2024-05-28
20914 ºÎ»ê Á¦6ȸ ºÎ»ê¼º¸ðº´¿ø ¼Ò¾Æû¼Ò³â°ú ½ÉÆ÷Áö¾ö : 2024-07-13 0 33 2024-05-28
20913 ¼­¿ï 2024 ´ëÇѽŰ泻ºÐºñ¿¬±¸È¸ ¿¬¼ö°­Á : 2024-07-13 0 36 2024-05-28
20912 ¼­¿ï ÀºÆò±¸ÀÇ»çȸ Á¦3Â÷¿¬¼ö±³À° : 2024-07-11 0 42 2024-05-28
20911 ¼­¿ï (¿Â¶óÀÎ) 2024³â ¼Ò¾Æ½ÅÀå Post-graduate education course : 2024-07-08 0 45 2024-05-28
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷